Skip to main navigation
  • About
    • About Us
    • Management Team
    • Board of Directors
    • Timeline
  • Pipeline
    • Overview
    • Hepatitis C Virus
    • Hepatitis B Virus
    • Respiratory Syncytial Virus
    • SARS-CoV-2
    • Immunology
  • Science
    • Overview
    • Publications
  • Patients
    • Overview
    • Clinical Trials
    • Expanded Access Policy
    • Resources
  • Careers
    • Join Us
    • Culture
    • Core Values
    • Testimonials
    • Benefits
  • Collaborations
    • Partnering
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Financials
      • Quarterly Results
      • Annual Reports
      • SEC Filings
    • Corporate Responsibility
      • Overview
      • Environmental
      • Social
      • Governance
    • Investor Resources
      • Investor FAQs
      • RSS Feeds
    • 2026 Annual Meeting
    • Email Alerts
  • Contact Us

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financials
    • Quarterly Results
    • Annual Reports
    • SEC Filings
  • Corporate Responsibility
    • Overview
    • Environmental
    • Social
    • Governance
  • Investor Resources
    • Investor FAQs
    • RSS Feeds
  • Email Alerts
  • 2026 Annual Meeting

Q1 2026

  • Read more about Q1 2026

Q4 2025

  • Read more about Q4 2025

Q3 2025

  • Read more about Q3 2025

Q2 2025

  • Read more about Q2 2025

Q1 2025

  • Read more about Q1 2025

Q4 2024

  • Read more about Q4 2024

Q3 2024

  • Read more about Q3 2024

Q2 2024

  • Read more about Q2 2024

Q1 2024

  • Read more about Q1 2024

Q4 2023

  • Read more about Q4 2023

Pagination

  • Page 1
  • Next page ››
Subscribe to Quarterly Results
  • Print Page Print Page
  • Email Alerts Email Alerts
  • RSS Feeds RSS Feeds
  • Contact IR Contact IR
enanta logo

©2026 Enanta Pharmaceuticals, Inc.

ENANTA PHARMACEUTICALS and accompanying logos are trademarks or registered trademarks of Enanta Pharmaceuticals, Inc.

Explore

  • About
  • Pipeline
  • Science
  • Patients
  • Careers
  • Collaborations
  • Investors
  • Contact Us

Contact

Enanta Pharmaceuticals, Inc. Headquarters
4 Kingsbury Avenue
Watertown, MA 02472

(617) 607-0800
info@enanta.com

Legal

  • Privacy Policy
  • Terms of Use
social media iconTwitter social media iconLinkedin
MENU
  • About
    • About Us
    • Management Team
    • Board of Directors
    • Timeline
  • Pipeline
    • Overview
    • Hepatitis C Virus
    • Hepatitis B Virus
    • Respiratory Syncytial Virus
    • SARS-CoV-2
    • Immunology
  • Science
    • Overview
    • Publications
  • Patients
    • Overview
    • Clinical Trials
    • Expanded Access Policy
    • Resources
  • Careers
    • Join Us
    • Culture
    • Core Values
    • Testimonials
    • Benefits
  • Collaborations
    • Partnering
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Financials
      • Quarterly Results
      • Annual Reports
      • SEC Filings
    • Corporate Responsibility
      • Overview
      • Environmental
      • Social
      • Governance
    • Investor Resources
      • Investor FAQs
      • RSS Feeds
    • 2026 Annual Meeting
    • Email Alerts
  • Contact Us